Switzerland warns against using ‘Lemon Bottle’ fat-dissolving injections
Switzerland's drug regulator Swissmedic has issued a warning about the “Lemon Bottle” fat-burning jab which has taken social media by storm. It advises against using the product which has “no medicinal effect”.
This content was published on
2 minutes
Keystone-SDA
In a statement on Tuesday, the Swiss Agency for Therapeutic Products (Swissmedic) warned against using “Lemon Bottle” lipolysis solution.
“No medicinal effect has been scientifically proven, the quality of the ingredients has not been tested and using the product may therefore pose a health risk,” it said.
Swissmedic classifies “Lemon Bottle” as a medicinal product because of its composition and the way it is administered by injection. The product has been promoted on social networks such as TikTok and the internet for its effects in reducing fat deposits on the face and certain parts of the body.
The Swiss regulator has analysed “Lemon Bottle” samples injected into adipose tissue (body fat) from various sources. It found that ingredient declarations varied significantly from one sample to another and were misleading.
The packaging states that “Lemon Bottle” contains mainly bromelain, lecithin and riboflavin, as well as a series of natural ingredients. But when Swissmedic conducted tests, it found that the composition did not correspond to the declaration, with some samples containing none of the ingredients indicated on the packaging.
As the quality of the ingredients is not controlled, the use of “Lemon Bottle” may present health risks, Swissmedic warns. It points out that any product that can be injected under the skin, such as “Lemon Bottle”, falls into the category of medicinal products subject to authorisation and may not be marketed as a cosmetic product.
Adapted from French by DeepL/sb
This news story has been written and carefully fact-checked by an external editorial team. At SWI swissinfo.ch we select the most relevant news for an international audience and use automatic translation tools such as DeepL to translate it into English. Providing you with automatically translated news gives us the time to write more in-depth articles.
If you want to know more about how we work, have a look here, and if you have feedback on this news story please write to english@swissinfo.ch.
External Content
Your subscription could not be saved. Please try again.
Almost finished… We need to confirm your email address. To complete the subscription process, please click the link in the email we just sent you.
Popular Stories
More
Banking & Fintech
UBS releases ‘hundreds’ of staff in fresh wave of job cuts
Should Switzerland take measures to support its struggling industries?
Industrial policies are back in fashion, not only in the United States but also in the EU. Should Switzerland, where various industries are struggling, draw inspiration from such policies?
Milei orders Argentina’s withdrawal from the World Health Organization
This content was published on
Argentina’s president, Javier Milei, has announced plans to pull the country out of the Geneva-headquartered World Health Organization (WHO).
‘Europe’ initiative halts signature collection to focus on Swiss-EU treaty
This content was published on
The initiative sought to embed Swiss-EU relations in the Federal Constitution, but the organisers have now stopped signature collection.
Swiss study sheds light on link between obesity and metabolic diseases
This content was published on
ETH Zurich researchers collected cells from overweight individuals to identify biological markers that raise the risk of metabolic diseases.
Swiss retail sector sees slight decline despite strong online sales
This content was published on
Black Friday, which performed well in some areas of Switzerland, and Christmas sales could not make up for the losses of previous months.
Over 6,000 Swiss companies go bankrupt but start-ups see growth
This content was published on
Switzerland recorded a spike in bankruptcies last year, but there was also a rise in new start-ups. Trends varied significantly by region and sector.
Basel greenlights funding for Eurovision Village 2025
This content was published on
MCH Group Ltd. is set to receive CHF1 million ($1.1 million) for the Eurovision Village at the Eurovision Song Contest 2025 in Basel.
Geneva researchers discover potential for targeted cancer drug delivery
This content was published on
Researchers in Geneva have discovered how some bacteria inject dangerous enzymes into cells, potentially enabling targeted drug delivery to cancer cells.
Macron denies involvement in Nestlé Waters scandal
This content was published on
French President Emmanuel Macron denied any “agreement” or “collusion” with the Swiss company Nestlé over the bottled water scandal on Tuesday.
This content was published on
Erection enhancers are the most frequently illegally imported medicines to Switzerland, followed by sleeping pills and sedatives.
Swiss medicine regulator warns against purchase of fake Ozempic
This content was published on
Swissmedic warns against the purchase of drugs from unknown sources after reports of hospitalisations due to fake Ozempic pens.
Pharma obesity market: Roche seeks deals to challenge Lilly and Novo
This content was published on
Roche isn’t done making moves in the obesity market after last month’s agreement to buy Carmot Therapeutics Inc. for $3.1 billion (CHF2.64 billion).
Swiss alliance calls for obesity to be recognised as a disease
This content was published on
The Swiss Obesity Alliance wants to classify obesity as a disease in the revision of the national strategy on “non-communicable diseases”.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.